2025
2025 A promising step forward in infection diagnostics It’s encouraging to see innovative diagnostic solutions like TriVerity from Inflammatix gaining recognition in the U.S. healthcare landscape. Such advancements are vital in improving outcomes for patients suffering from acute infections, including critical conditions like sepsis. Congratulations to team Inflammatix! To learn more about TriVerity and its […]
2024
2024 Delphine Diagnostics Showcases AI Innovations at BioNJ’s 2024 AI & Digital Health Day Hoboken, NJ. November 18, 2024 Delphine Diagnostics is proud to announce its participation in the 2nd Annual AI & Digital Health Day, hosted by BioNJ on November 18, 2024, at Stevens Institute of Technology in Hoboken, NJ. This event brought together […]
2023
2023 Delphine Diagnostics Takes Center Stage at NJ Cores Partnering Conference Princeton, NJ. June 2023:Delphine Diagnostics, a pioneering figure in advanced medical diagnostics, proudly showcased its commitment to scientific collaboration and innovation at the recently concluded New Jersey Research Cores Partnering Conference held this June. The conference brought together leading minds and emerging talents from […]
2022
2022 BioNJ Manufacturing Briefing 2022 Newark, NJ. September 9, 2022: Delphine Diagnostics’ CEO, Andy Bala, attended Manufacturing Briefing 2022 at NJIT and NJ Innovation Institute, both in Newark, NJ. The event was in-person and organized by BioNJ. BioNJ, McKinsey, a few big pharma firms, and FDA came together to share forward-looking updates relevant to the BioPharma […]
A Meaningful Collaboration Between Rutgers Business School and Delphine Diagnostics Inc
A Meaningful Collaboration Between Rutgers Business School and Delphine Diagnostics Inc In the pictures: Delphine’s CEO, Andy (Andiappan) Bala, is working with the Rutgers Business School students. The students are serving in an excelling program and gaining real work-life experiences. The rewards are countless when investing in young minds, collaboration, expertise, and access.
Healthcare companies discuss their interest in establishing themselves in Puerto Rico
Healthcare companies discuss their interest in establishing themselves in Puerto Rico We are so thrilled that Delphine Diagnostics’ leadership team participated in the Puerto Rico Biosciences Emerging Companies Network. Our presentation received significant attention, and we made new connections on the island. Special thanks to A4G, The Puerto Rico Economic Development Alliance, for organizing such […]
Human Genomics and COVID-19
Human Genomics and COVID-19 The Human Genome is a beautiful and intricate system that encodes and inscribes the biological functions of our body. This multi-faceted blueprint is critical for not only creating and sustaining the human body, but protecting it as well. However, when it comes to mutated viruses that have expanded their host range to humans, the human genome is far from flawless in encoding mitigation mechanisms. According to […]
Covid-19: Should we be worried about reports of myocarditis and pericarditis after mRNA vaccines?
Covid-19: Should we be worried about reports of myocarditis and pericarditis after mRNA vaccines? What is the latest? On 23 June the US Centers for Disease Control and Prevention’s safety committee said there was a “likely association” between the Pfizer-BioNTech and Moderna covid-19 vaccines and myocarditis and pericarditis in some young adults. The CDC’s Advisory […]
Delphine’s PrecisQT™ not affected by known SARS-CoV-2 VariantsCovid-19: Should we be worried about reports of myocarditis and pericarditis after mRNA vaccines?
A Perspective on the COVID-19 Vaccine Changes to the SARS-CoV-2 genome—including some of those found in currently circulating variants—can negatively affect the detection of the virus by reverse transcription (RT) PCR, according to a study published on April 26 in the Journal of Clinical Microbiology. The researchers propose that mutations in the loci recognized by DNA […]
Delphine Notification Accepted by FDA
Delphine Notification Accepted by FDA Delphine Diagnostics Inc., Bordentown, New Jersey, has been informed by the FDA’s Center for Devices and Radiological Health (CDRH) that its Notification of Intent to Distribute the Delphine PrecisQT™ COVID-19 Test Kit has been accepted under Section IV.C.2 of the FDA’s Policy for Coronavirus Disease-2019 Tests. Delphine PrecisQT™ is now […]
